BRD4 and prostate carcinoma: In prostate cancer, higher nuclear BRD4 protein expression in pre-treatment tumor samples is associated with higher rate of treatment failure in patients receiving RT as a part of primary treatment, suggesting that BRD4 plays an important role in RR10.